SoundHealth Launches Spatial Sleep: The World’s First Clinically Proven, Personalized, Drug-Free Wearable for Better Sleep
SoundHealth, a medical technology company using AI and medical science to improve patient outcomes, today announced the launch of Spatial Sleep, a personalized acoustic sleep headband to help people fall asleep faster, sleep longer and wake up refreshed.
SONU by SoundHealth Named to TIME’s List of the Best Inventions of 2025
SoundHealth is proud to announce its SONU Band has been selected as one of TIME’s Best Inventions of 2025 in the Health & Wellness category. This recognition underscores SoundHealth’s promise to harness the power of artificial intelligence and medical science to improve respiratory health. SONU is an FDA-approved, drug-free wearable that uses acoustic therapy to relieve nasal congestion and help you breathe easier.
SoundHealth to Present Revolutionary AI-Powered Airway Screening Tool at World Sleep 2025
SoundHealth, a medical technology company harnessing the power of AI and science to improve respiratory health, will present its groundbreaking AI-powered mobile platform, Airway, at World Sleep 2025 in Singapore this September. The scalable smartphone-based airways tool was designed to screen for obstructive sleep apnea and sleep disordered breathing in pediatric and adult populations. The presentation will be delivered by a team of physicians and experts, including SoundHealth's CEO and founder, Paramesh Gopi, PhD.
SoundHealth Launches Android App for Its FDA-Approved SONU Band
SoundHealth, the medical technology company behind the SONU Band, has launched the first-ever medical-grade Android app capable of transforming a selfie into CT-accurate skeletal data for the treatment of rhinitis. The SONU Band is the world’s first FDA De Novo authorized, AI-enabled wearable medical device that uses sound-based therapy to relieve moderate to severe nasal congestion and allergy symptoms at home and without the need for drugs or sprays.
SONU Band by SoundHealth Receives Pediatric FDA Approval
SoundHealth, a medical technology company harnessing the power of artificial intelligence and medical science to improve patient outcomes, announced it received United States Food and Drug Administration (FDA) approval for pediatric use of its groundbreaking SONU Band. SONU is the world’s first FDA De Novo authorized, AI-enabled, wearable medical device for at-home treatment of moderate to severe nasal congestion due to allergic and non-allergic rhinitis. This expanded approval makes SONU the first FDA-approved, drug-free solution for nasal congestion and allergies in children ages 12 and up, providing a safe alternative to pharmaceutical treatments.
First Ever Large-Scale Study Linking Nasal Anatomy to Allergy Symptoms, Unveiled at Leading Allergy, Asthma and Immunology Conference
A groundbreaking study, presented at the Western Allergy Conference 2025, is the first large-scale investigation to examine how nasal anatomy influences upper airway allergies using real-world data from thousands of patients. This large-scale study is the first of its kind to leverage computational fluid dynamics (CFD) modeling with real-world patient data, marking a paradigm shift in allergy research and advancing personalized, precision medicine.
Acoustic Resonance Therapy Offers Promising Treatment for Chronic Insomnia
A groundbreaking study from researchers at Stanford Medicine and SoundHealth presents a new, non-invasive therapy for chronic insomnia using customized binaural spatial audio delivered via an acoustic resonance therapy (ART) headband. Chronic insomnia, which affects 10% to 15% of the adult population, often leads to reduced quality of life and is associated with multiple health risks, including cardiovascular disease and depression.
